HLNHaleon plc American Depositary Shares (Each representing two Ordinary Shares)
Identity
- Security key
- 16549
- Ticker
- HLN
- Type
- ADRC — American Depository Receipt Common
- Exchange
- New York Stock Exchange(XNYS)
- Venue group
- NYSE
- Operating MIC
- XNYS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2022-07-18
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- HLN
Detail
Enriched 2026-08-14 20:47
- Market cap
- $43,157,860,447.8
- Shares outstanding (class)
- 4,404,449,854
- Shares outstanding (weighted)
- 4,403,863,311
- SIC
- —
- Employees
- 24,524
- Location
- —
- Homepage
- https://www.haleon.com
- Description
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.